A Remote, 9-week Insomnia Treatment Trial to Collect Real World Data for a Digital Therapeutic

Inclusion Criteria: 1. Provide electronic informed consent prior to any study specific assessments being performed 2. Between 22 and 75 years old, inclusively 3. Insomnia as defined by an ISI score of 8 or above 4. Insomnia symptoms for at least 3 months 5. \< or = 6.5 hours of sleep per night 6. Access to a mobile device 7. Resident of the United States and currently living in the United States for the duration of the trial. Exclusion Criteria: 1. Presence of an active and/or progressive physical illness (e.g., congestive-heart failure, chronic obstructive pulmonary disease, acute pain), neurological disorder (e.g., epilepsy) or neurological degenerative diseases (e.g., dementia, multiple sclerosis) 2. Unstable medication regimen (change to schedule or dosage within the past 3 months) 3. Diagnosis of a psychotic disorder or bipolar disorder or medical condition contraindicated by sleep restriction 4. Have family or work schedules that prevent them from having normal sleep schedules defined as bedtime between 8:00 pm and 2:00 am and/or waking times between 4:00 am and 10:00 am. 5. Individuals who need to be alert or cautious to avoid serious accidents in their job or daily life. Examples include: Long-haul truck drivers, Long-distance bus drivers, Air traffic controllers, Operators of heavy machinery, some assembly line jobs. 6. Pregnant or planning to become pregnant during the course of the trial. 7. Other untreated sleep disorders as self-reported by the participant (e.g., obstructive sleep apnea, periodic leg movements, parasomnias) 8. Participated in an investigational research study in the past 30 days